KCM Investment Advisors LLC Sells 8,049 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

KCM Investment Advisors LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 39.3% during the 4th quarter, HoldingsChannel reports. The fund owned 12,431 shares of the healthcare conglomerate’s stock after selling 8,049 shares during the quarter. KCM Investment Advisors LLC’s holdings in UnitedHealth Group were worth $6,288,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of UNH. NewSquare Capital LLC bought a new position in UnitedHealth Group in the fourth quarter valued at $25,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at about $30,000. Promus Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter worth about $32,000. Pillar Financial Advisors LLC bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $40,000. Finally, DecisionPoint Financial LLC boosted its holdings in shares of UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after buying an additional 62 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of recent analyst reports. Wells Fargo & Company cut their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Barclays lowered their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Truist Financial reduced their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a report on Friday, January 10th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $629.32.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Down 2.9 %

UNH stock opened at $524.94 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a market cap of $480.17 billion, a PE ratio of 33.87, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The business has a 50-day simple moving average of $509.24 and a 200 day simple moving average of $542.37.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the business earned $5.83 earnings per share. The company’s revenue was up 6.8% on a year-over-year basis. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.60%. UnitedHealth Group’s payout ratio is currently 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.